Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders
Potential Direct Cardiovascular Effects: While the primary mechanisms of cardiovascular benefit are likely mediated through weight loss and metabolic improvements, some preclinical and early clinical data suggest that GLP-1 receptor agonists, and potentially GIP receptor agonists, may have direct effects on the heart and blood vessels, such as reducing inflammation and improving endothelial function
In addition, 89.2% of subjects receiving oral semaglutide (50 mg) lost 5% or more of their body weight at 68 weeks, compared to 24.5% with placebo
In large clinical trials, tirzepatide demonstrated significant total body weight loss over time
PlexusDx serves all 50 states without requiring insurance
Tighter rules could also result in fewer employees accessing the medication or shifting costs elsewhere in the healthcare plan